Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069
- 1 September 1984
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (9), 1657-1660
- https://doi.org/10.1016/0360-3016(84)90522-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Modification of chemotherapy by nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivoBritish Journal of Cancer, 1984
- The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouseBritish Journal of Cancer, 1983
- Potentiation of chemotherapy by hypoxic cell radiation sensitizers—A reviewInternational Journal of Radiation Oncology*Biology*Physics, 1982
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Potentiation in vivo of melphalan activity by nitroimidazole compoundsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: Structure-activity relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Enhancement of chemotherapy agentsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- In vivo combination of misonidazole and the chemotherapeutic agent CCNUBritish Journal of Cancer, 1981